When was Mammoth founded?

Mammoth was founded in 2017 and became a unicorn in 2021.

Where is Mammoth located?

Mammoth is headquartered in Brisbane, United States.

Who is the current CEO of Mammoth?

Trevor Martin of Mammoth. They have also founded 1 company and are angel investors in 4 startups, including .

How many employees does Mammoth have?

As of Mar 31, 2026, the latest employee count at Mammoth is 167.

Is Mammoth a funded company?

Mammoth is a funded company, having raised a total of $271M across 7 funding rounds to date. The company's 1st funding round was a $120K Seed round, raised on Sep 14, 2017.

How much is Mammoth worth?

The latest valuation of Mammoth is $1B as of Sep 09, 2021.

When was the latest funding round of Mammoth?

Mammoth's latest funding was a $150M Series D round on Sep 09, 2021, with participation from 9 investors. Its primary sector is Genomics. In United States, the Genomics sector has seen $455M in funding in 2026 to date.

Is Mammoth a Genomics company?

The primary sectors of Mammoth are Genomics, Gastroenterology, Rare Diseases and Neurology.

Where does Mammoth rank among its competitors?

Mammoth ranks 26th amongst 776 active competitors, of which 272 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Intra-Cellular Therapies, which secured $6.17M in Apr, 2025.

Who are the top competitors of Mammoth?

Mammoth's top competitors include Jazz Pharmaceuticals, Pacira and Intra-Cellular Therapies. Among them, Intra-Cellular Therapies secured the most recent funding round in April, 2025.

Mammoth - 2026 Company Profile, Team, Funding & Competitors

Sectors and market segments that Mammoth operate in

Mammoth serves in the Life Sciences market segments.The primary business model of Mammoth are:

Company Details

Mammoth Biosciences offers a CRISPR data platform for diagnostics using Cas12 and Cas13 proteins. The company is creating a new class of diagnostics for industries ranging from oil and gas to agriculture to healthcare. The platform is used to identify disease-causing biomarkers (DNA/RNA).

Website: mammoth.bio
Social
Email ID: *****@mammothbiosci.com
Phone Number: +1 **********

Key Metrics

Founded Year

2017

Location

Brisbane, United States

Stage

Series D

Total Funding

$271M in 7 rounds

Latest Funding Round

Series D, Sep 09, 2021, $150M

Post Money Valuation

$1B as on Sep 09, 2021

Investors

Redmile Group & 35 more

Ranked

26^th among 776 active competitors

Employee Count

167 as on Mar 31, 2026

Similar Companies

Passage Bio & 307 more

View Mammoth's full profile

Mammoth has raised a total funding of $271M over 7 rounds. Its first funding round was on Sep 14, 2017. Its latest funding round was a Series D round on Sep 09, 2021 for $150M. 9 investors participated in its latest round. Mammoth has 32 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of Mammoth:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 09, 2021	$150M	Series D	$1B	-	Redmile Group	Foresite Capital, Greenspring Associates, Decheng Capital, Mayfield, Senator Investment Group, Plum Alley Investments, NFX, Sixth Street
Jan 26, 2021	Undisclosed	Series C	-	-	-	-
2020	$45M	Series C	-	-	Redmile Group	Foresite Capital, Sixth Street, Decheng Capital, Mayfield, Amazon India

Access funding benchmarks and valuations. Sign up today!

View details of Mammoth's funding rounds and investors

The founders of Mammoth are Trevor Martin, Lucas Harrington, Janice Chen and Jennifer Doudna. Trevor Martin is the CEO of Mammoth.

Here are the details of Mammoth's key team members:

Trevor Martin: Co-Founder & CEO of Mammoth. They are also an angel investor in 4 startups.
Contact Info: 1 email address
Lucas Harrington: Co-Founder & CSO of Mammoth and founder of 1 other company.
Contact Info: 2 email addresses
Janice Chen: Co-founder & CTO of Mammoth.
Jennifer Doudna: Co-Founder of Mammoth.

View details of Mammoth's Founder profiles and Board Members

Mammoth's employee count trend

Mammoth has 167 employees as of Mar 26. Here is Mammoth's employee count trend over the years:

Uncover Mammoth's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Mammoth include Jazz Pharmaceuticals, Pacira and Intra-Cellular Therapies. Here is the list of Top 10 competitors of Mammoth, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Pacira 2006, Parsippany Troy Hills (United States), Public	Developer of injectable non-opioid products for post-surgical pain control	$85M	HBM Healthcare Investments, Orbimed & 6 others	72/100
3rd	Intra-Cellular Therapies 2002, New York City (United States), Acquired	Developer of therapeutics for psychiatric and neurologic diseases	$80.9M	BB Biotech, International Biotechnology Trust ... & 6 others	70/100
4th	Passage Bio 2017, Philadelphia (United States), Public	Developer of gene therapies for CNS rare diseases	$226M	Access Biotechnology, Orbimed & 10 others	69/100
5th	Lundbeck 1915, Copenhagen (Denmark), Public	Developer of drugs for treating CNS disorders	-	Impact Fund Denmark, Europa	69/100
6th	Neurocrine 1992, San Diego (United States), Acquired	Developer of small molecule therapeutics for endocrine and CNS disorders	$10M	BB Biotech, Venrock & 5 others	69/100
7th	Healx 2014, Cambridge (United Kingdom), Series C	AI-powered drug discovery platform to treat rare diseases	$115M	Atomico, Balderton Capital & 18 others	69/100
8th	Nimbus Therapeutics 2009, Cambridge (United States), Series F	Developer of targeted therapeutics for cancer, metabolic and inflammatory diseases	$637M	BVF Partners, Atlas Venture & 20 others	68/100
9th	Septerna 2020, San Bruno (United States), Public	Developer of GPCR drug discovery platform for multiple diseases	$250M	RA Capital Management, Third Rock Ventures ... & 14 others	68/100
10th	AskBio 2001, Durham (United States), Acquired	Developer of AAV technologies for treating genetic and complex disorders	$235M	Vida Ventures, TPG & 4 others	68/100
26th	Mammoth 2017, Brisbane (United States), Series D	Provider of molecular diagnostics platform by using CRISPR technology	$271M	Redmile Group, Sixth Street & 34 others	65/100